Abstract:Background and Aims:The active metabolite of vitamin D 3 , 1,25-dihydroxyvitamin D 33 ) inhibits cell growth and induces cell differentiation and apoptosis in numerous tumors, such as colon, breast and prostate cancers.The role of 1,25-D 3 in the development of the hepatocellular carcinoma has not yet been established.The aim of the present study was to examine the gene expression of the vitamin D inactivating CYP24A1 as well as the activating 1-alpha-hydroxylase (CYP27B1) enzyme after 1,25-D 3 treatment in hepatocellular carcinoma cell lines (1,25-D).Methods: HepG2 and HUHneo (Dept. of Molecular Virology, Univ. of Heidelberg) cells were treated with 4 nM concentrations of 1,25-D 3 in Optimem medium and were incubated in 24-well plates in two parallels for treatment duration of 30, 60, 120 minutes, 5, 8, 10, 12, 14, 24, 26, 28 hours.Total RNA was isolated from each sample with Roche High Pure Total RNA Isolation kit.Five hundred ng of total RNA was reverse-transcribed to cDNA.The expression differences of selected genes were analyzed by Taqman probe-based quantitative real-time PCR.Relative quantification was carried out from collected data (threshold cycle numbers) by Applied Biosystems 7500 System SDS software 1.3.Results: CYP24A1 mRNA expression significantly (p < 0.001) increased in response to 1,25-D 3 administration in a timedependent manner in both cell lines.In HepG2 cell line the CYP24A1 mRNA expression showed 5300-fold elevation reaching the maximum value at 8 hours.In the HUHneo cells the increase was 152-fold of the baseline level, and the curve reached the maximum at 14 hours.There was no change in CYP27B1 gene activity of the cells treated with 1,25-D 3 .The activating effect of vitamin D3 on CYP24 mRNA expression was at 28 hours still detectable.Conclusions: Our novel data raise the possibility that the significant increase in the CYP24A1 gene expression of hepatocellular carcinoma cell lines following vitamin D administration may stimulate the inactivation of 1,25-D 3, thus "protecting" the tumor cells against the anti-cancer effects of 1,25-D 3.This is the first report on the role of vitamin D3 on the CYP24A1 mRNA transcription in hepatocellular carcinoma cells in vitro.

1Α,25-Dihydroxyvitamin D3 Inhibits Aflatoxin B1-Induced Proliferation and Malignant Transformation of Hepatic Progenitor Cells by Regulating PI3K/Akt and Hippo Pathways

1, 25(Oh)(2)D-3 Inhibits Hepatocellular Carcinoma Development Through Reducing Secretion Of Inflammatory Cytokines From Immunocytes

AFB1 Triggers Lipid Metabolism Disorders through the PI3K/Akt Pathway and Mediates Apoptosis Leading to Hepatotoxicity

20-hydroxyvitamin D₃ inhibits proliferation of cancer cells with high efficacy while being non-toxic.

226 THE PROGNOSTIC SIGNIFICANCE OF PREOPERATIVE SERUM LEVELS OF EXTRACELLULAR MATRIX PROTEIN 1 IN PATIENTS WITH HEPATOCELLULAR CARCINOMA

Clinical Features of Aflatoxin B1-exposed Patients with Liver Cancer and the Molecular Mechanism of Aflatoxin B1 on Liver Cancer Cells.

Cathelicidin Hcap18/ll-37 Promotes Cell Proliferation and Suppresses Antitumor Activity of 1,25(OH)2D3 in Hepatocellular Carcinoma.

Aflatoxin B1 downregulates ARID3 genes to overcome senescence for inducing hepatocellular carcinoma

Comprehensive Metabolomic Analysis Reveals Dynamic Metabolic Reprogramming in Hep3B Cells with Aflatoxin B1 Exposure

Vitamin D3 supplementation alleviates chemically-induced cirrhosis-associated hepatocarcinogenesis

The study of vitamin D analogue EB1089 on the proliferation of hepatocellular carcinoma cells

Aflatoxin B1 Up-Regulates Insulin Receptor Substrate 2 And Stimulates Hepatoma Cell Migration

Activity and Significance of CYP3A4 in Aflatoxin B1-induced Hepatocarcinogenesis in Wistar Rats

Daintain/AIF-1 accelerates the activation of insulin-like growth factor-1 receptor signaling pathway in HepG2 cells.

Effect of Specific Inhibition of JAK/STAT3 Signaling Pathway on Hepatocellular Carcinoma in Rats

Inhibitory Effect of 1,25(OH)2D3 on Proliferation of Human Laryngeal Carcinoma Cells and Potential Mechanisms

1,25(OH)2D3 Protects Liver Fibrosis Through Decreasing the Generation of TH17 Cells.

Integrated Network Toxicology, Molecular Docking, and in Vivo Experiments to Elucidate Molecular Mechanism of Aflatoxin B1 Hepatotoxicity

1,25(OH)2D3 Attenuates IL-1β-Induced Epithelial-to-Mesenchymal Transition Through Inhibiting the Expression of Lnctcf7.

Cthrc1 Inhibits Proliferation of Hepatic Stellate Cells in Mice

Antiproliferative Effects of 1α,25-Dihydroxyvitamin D3 and Vitamin D Analogs on Tumor-Derived Endothelial Cells